Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.00
Bid: 40.00
Ask: 42.00
Change: 0.00 (0.00%)
Spread: 2.00 (5.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 41.00
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

28 Oct 2021 07:00

RNS Number : 4962Q
Frontier IP Group plc
28 October 2021
 

RNS

AIM: FIPP

28 October 2021

 

Frontier IP Group Plc

("Frontier IP" or the "Group")

 

Board changes

 

Frontier IP, a specialist in commercialising intellectual property, announces the appointment of Professor Dame Julia King, Baroness Brown of Cambridge DBE FREng FRS, as an independent Non-Executive Director effective from 28 October 2021.

 

In addition the Company announces that Michael Bourne, currently an independent Non-Executive Director, has notified the Company that, having served on the Board for more than seven years, he has decided to step down from his non-executive role at Frontier IP. Michael will remain on the board until the Company's forthcoming annual general meeting to be held on 9 December 2021 where he will not seek re-election as a director.

 

Baroness Brown is an engineer with immense experience across industry and government. Following an academic career at Cambridge University, Julia held senior engineering and business roles at Rolls-Royce between 1994 and 2002, before returning to academia as Principal of Engineering at Imperial College and then as Vice Chancellor and Chief Executive of Aston University from 2006-2016. She is currently Chair of The Carbon Trust, a non-executive director of Ørsted, Chair of the Adaptation Committee of the Climate Change Committee, a member of the BEIS Hydrogen Advisory Council and a Non-Executive Director of AIM quoted Ceres Power Holdings plc.

 

Julia is passionate about education and engineering and contributed to the Browne report on university funding and to Lord Stern's review on the research excellence framework. She Chairs STEM Learning Limited and is the Chair of the Governing Board at the Henry Royce Institute for Advanced Materials.

 

Julia is a Fellow of the Royal Academy of Engineering, a Fellow of the Royal Society and was awarded a DBE for services to higher education and technology. In 2015 she was elevated to the Peerage as the Baroness Brown of Cambridge and sits as a Crossbench Peer in the House of Lords where she is a member of the Science and Technology Select Committee.

 

Neil Crabb, Chief Executive Officer of Frontier IP Group Plc, commented: "I am delighted to welcome Julia to our Board of Directors. To attract someone of her standing and experience across academia, industry and in tackling climate change represents a strong endorsement of our approach and potential. Her backing will be invaluable as we push Frontier IP forward to the next phase of growth.

 

I would also very much like to thank Mike for all his counsel and support over the past seven years. He has played a vital part in helping us get to where we are today."

 

Professor Dame Julia King, Baroness Brown of Cambridge DBE FREng FRS, said: "I am delighted to be joining Frontier IP Group. I have always felt that commercialising research, especially university research, needed a very engaged, hands-on approach, so Frontier's model really appeals to me. Recent results show that it seems to be working."

 

Ends

 

ENQUIRIES

 

Frontier IP Group Plc

Neil Crabb, Chief Executive

Andrew Johnson, Communications & Investor Relations

Company website: www.frontierip.co.uk

 

T: 020 3968 7815 neil@frontierip.co.uk

M: 07464 546 025

Allenby Capital Limited (Nominated Adviser)

Nick Athanas / George Payne

 

T: 0203 328 5656

Singer Capital Markets (Broker)

Sandy Fraser / Harry Gooden / George Tzimas

T: 0207 496 3000

 

 

Further regulatory disclosures

 

The following additional information is provided in accordance with Rule 17 and Schedule Two Paragraph (g) of the AIM Rules.

 

Julia Elizabeth King (age 67), Baroness Brown of Cambridge is, or has during the last five years, been a director or partner of the following companies and partnerships:

 

Current Directorships or Partnerships

Previous Directorships or Partnerships

Ceres Power Holdings plc

The Carbon Trust

Stem Learning Limited

Ørsted A/S (Denmark)

Carbon Trust Investments Limited

UK Green Investment Bank Limited

Offshore Renewable Energy Catapult

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAVDLFLFBLFFBL
Date   Source Headline
2nd May 20247:00 amRNSFrontier IP announces stake in DiaGen
17th Apr 20241:59 pmRNSHolding(s) in Company
12th Apr 20247:00 amRNSAppointment of Chief Financial Officer
2nd Apr 202412:44 pmRNSHolding(s) in Company
14th Mar 20247:00 amRNSUnaudited Half Year Results
4th Mar 20241:40 pmRNSHolding(s) in Company
29th Feb 20243:12 pmRNSSale of shares in Exscientia
30th Jan 202411:45 amRNSHolding(s) in Company
22nd Jan 20247:00 amRNSOctopus invest in Alusid as part of equity funding
29th Dec 202312:00 pmRNSTotal Voting Rights
19th Dec 20234:46 pmRNSHolding(s) in Company
15th Dec 20236:12 pmRNSReplacement - Result of AGM and Directorate Change
15th Dec 20232:07 pmRNSResult of AGM and Directorate Change
13th Dec 20237:00 amRNSPortfolio news - The Vaccine Group
11th Dec 20237:00 amRNSHolding(s) in Company
30th Nov 20235:00 pmRNSTotal Voting Rights
30th Nov 20237:00 amRNSExercise of Options & Director/PDMR Shareholdings
28th Nov 20237:00 amRNSBoard Change
21st Nov 20237:00 amRNSPosting of Annual Report and Notice of AGM
9th Nov 20235:27 pmRNSHolding(s) in Company
3rd Nov 20237:05 amRNSGrant of options
1st Nov 20235:48 pmRNSExercise of Options & PDMR Shareholdings & TVR
31st Oct 20237:01 amRNSBoard changes
31st Oct 20237:00 amRNSFinal results for the year ended 30 June 2023
23rd Oct 20237:00 amRNSNew portfolio company Deakin Bio-Hybrid Materials
12th Oct 20232:05 pmRNSHolding(s) in Company
21st Sep 20237:00 amRNSExscientia announces collaboration with Merck
14th Sep 20235:21 pmRNSHolding(s) in Company
14th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
11th Sep 20237:00 amRNSPortfolio news – Pulsiv appoints Chairman and CPO
8th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
10th Aug 20238:45 amRNSPortfolio news – Fieldwork Robotics
24th Jul 20237:00 amRNSPortfolio news – CamGraPhIC loan facility
20th Jul 20235:18 pmRNSHolding(s) in Company
1st Jun 20237:00 amRNSSale of shares in Exscientia
26th May 20236:06 pmRNSHolding(s) in Company
9th May 20237:00 amRNSTopps Tiles launches first Alusid made tile range
21st Apr 20234:00 pmRNSDirectorate Change
20th Apr 20235:26 pmRNSHolding(s) in Company
27th Mar 20235:17 pmRNSHolding(s) in Company
17th Mar 20232:46 pmRNSGrant of options
15th Mar 20237:00 amRNSBoard changes
15th Mar 20237:00 amRNSUnaudited Half Year Results
30th Jan 20237:00 amRNSAlusid in collaboration with Imerys
9th Jan 20237:00 amRNSCelerum appoints David Gladding as CEO
9th Dec 20224:08 pmRNSResult of AGM
7th Dec 20221:25 pmEQSThe Vaccine Group completes two deadly disease vaccination projects
6th Dec 20227:00 amRNSFrontier IP to host Portfolio Demo Day
5th Dec 20227:00 amRNSThe Vaccine Group completes Lassa fever project
2nd Dec 20227:00 amRNSThe Vaccine Group completes vaccine project

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.